ABO blood group and cardiovacular disease the Framingham study

R. J. Garrison, R. J. Havlik, Robin B Harris, M. Feinleib, W. B. Kannel, S. J. Padgett

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Following determination of ABO blood type at the sixth biennial examination, the Framingham Heart Study cohort was followed for the occurrence of cardiovascular events for a period of 10 years. A significant association was found between blood type and intermittent claudication, with blood group O showing the lowest rates. Slight but non-significant excesses for certain other CHD events were also found in non-O individuals. Serum cholesterol showed marginally significant but consistent elevations in non-O subjects but the increased risk in non-O individuals was found to occur independently of the known intermittent claudication risk factors. Since the observed relationship between blood type and intermittent claudication occurs independently of the usual atherosclerotic risk factors, blood type, possibly through an effect on clotting, should be considered in the pathogenesis of intermittent claudication.

Original languageEnglish (US)
Pages (from-to)311-318
Number of pages8
JournalAtherosclerosis
Volume25
Issue number2-3
DOIs
StatePublished - 1976
Externally publishedYes

Fingerprint

Intermittent Claudication
Blood Group Antigens
Cohort Studies
Cholesterol
Serum

Keywords

  • ABO blood group
  • Atherosclerosis
  • Blood clotting
  • Cardiovascular disease
  • Epidemiology
  • Human genetics
  • Intermittent claudication

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Garrison, R. J., Havlik, R. J., Harris, R. B., Feinleib, M., Kannel, W. B., & Padgett, S. J. (1976). ABO blood group and cardiovacular disease the Framingham study. Atherosclerosis, 25(2-3), 311-318. https://doi.org/10.1016/0021-9150(76)90036-8

ABO blood group and cardiovacular disease the Framingham study. / Garrison, R. J.; Havlik, R. J.; Harris, Robin B; Feinleib, M.; Kannel, W. B.; Padgett, S. J.

In: Atherosclerosis, Vol. 25, No. 2-3, 1976, p. 311-318.

Research output: Contribution to journalArticle

Garrison, RJ, Havlik, RJ, Harris, RB, Feinleib, M, Kannel, WB & Padgett, SJ 1976, 'ABO blood group and cardiovacular disease the Framingham study', Atherosclerosis, vol. 25, no. 2-3, pp. 311-318. https://doi.org/10.1016/0021-9150(76)90036-8
Garrison, R. J. ; Havlik, R. J. ; Harris, Robin B ; Feinleib, M. ; Kannel, W. B. ; Padgett, S. J. / ABO blood group and cardiovacular disease the Framingham study. In: Atherosclerosis. 1976 ; Vol. 25, No. 2-3. pp. 311-318.
@article{2ded62b164ad47bfbd28255039c3a09f,
title = "ABO blood group and cardiovacular disease the Framingham study",
abstract = "Following determination of ABO blood type at the sixth biennial examination, the Framingham Heart Study cohort was followed for the occurrence of cardiovascular events for a period of 10 years. A significant association was found between blood type and intermittent claudication, with blood group O showing the lowest rates. Slight but non-significant excesses for certain other CHD events were also found in non-O individuals. Serum cholesterol showed marginally significant but consistent elevations in non-O subjects but the increased risk in non-O individuals was found to occur independently of the known intermittent claudication risk factors. Since the observed relationship between blood type and intermittent claudication occurs independently of the usual atherosclerotic risk factors, blood type, possibly through an effect on clotting, should be considered in the pathogenesis of intermittent claudication.",
keywords = "ABO blood group, Atherosclerosis, Blood clotting, Cardiovascular disease, Epidemiology, Human genetics, Intermittent claudication",
author = "Garrison, {R. J.} and Havlik, {R. J.} and Harris, {Robin B} and M. Feinleib and Kannel, {W. B.} and Padgett, {S. J.}",
year = "1976",
doi = "10.1016/0021-9150(76)90036-8",
language = "English (US)",
volume = "25",
pages = "311--318",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2-3",

}

TY - JOUR

T1 - ABO blood group and cardiovacular disease the Framingham study

AU - Garrison, R. J.

AU - Havlik, R. J.

AU - Harris, Robin B

AU - Feinleib, M.

AU - Kannel, W. B.

AU - Padgett, S. J.

PY - 1976

Y1 - 1976

N2 - Following determination of ABO blood type at the sixth biennial examination, the Framingham Heart Study cohort was followed for the occurrence of cardiovascular events for a period of 10 years. A significant association was found between blood type and intermittent claudication, with blood group O showing the lowest rates. Slight but non-significant excesses for certain other CHD events were also found in non-O individuals. Serum cholesterol showed marginally significant but consistent elevations in non-O subjects but the increased risk in non-O individuals was found to occur independently of the known intermittent claudication risk factors. Since the observed relationship between blood type and intermittent claudication occurs independently of the usual atherosclerotic risk factors, blood type, possibly through an effect on clotting, should be considered in the pathogenesis of intermittent claudication.

AB - Following determination of ABO blood type at the sixth biennial examination, the Framingham Heart Study cohort was followed for the occurrence of cardiovascular events for a period of 10 years. A significant association was found between blood type and intermittent claudication, with blood group O showing the lowest rates. Slight but non-significant excesses for certain other CHD events were also found in non-O individuals. Serum cholesterol showed marginally significant but consistent elevations in non-O subjects but the increased risk in non-O individuals was found to occur independently of the known intermittent claudication risk factors. Since the observed relationship between blood type and intermittent claudication occurs independently of the usual atherosclerotic risk factors, blood type, possibly through an effect on clotting, should be considered in the pathogenesis of intermittent claudication.

KW - ABO blood group

KW - Atherosclerosis

KW - Blood clotting

KW - Cardiovascular disease

KW - Epidemiology

KW - Human genetics

KW - Intermittent claudication

UR - http://www.scopus.com/inward/record.url?scp=0017018243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017018243&partnerID=8YFLogxK

U2 - 10.1016/0021-9150(76)90036-8

DO - 10.1016/0021-9150(76)90036-8

M3 - Article

C2 - 1008914

AN - SCOPUS:0017018243

VL - 25

SP - 311

EP - 318

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2-3

ER -